Hepatic functional imaging and genomics to predict irinotecan pharmacokinetics and pharmacodynamics: The PREDICT IR study

Simple item page
dc.contributor.authorMichael, M.
dc.contributor.authorLiauw, W.
dc.contributor.authorMcLachlan, S.-A.
dc.contributor.authorLink, E.
dc.contributor.authorMatera, A.
dc.contributor.authorThompson, M.
dc.contributor.authorJefford, M.
dc.contributor.authorHicks, R.J.
dc.contributor.authorCullinane, C.
dc.contributor.authorCampbell, I.
dc.contributor.authorBeale, P.J.
dc.contributor.authorKarapetis, C.S.
dc.contributor.authorPrice, T.J.
dc.contributor.authorBurge, M.E.
dc.contributor.conference42nd European Society for Medical Oncology Congress (ESMO) (8 Sep 2017 - 12 Sep 2017 : Madrid, SPAIN)
dc.date.issued2017
dc.descriptionIssue Section: Developmental therapeutics - Abstract #405P
dc.description.statementofresponsibilityM. Michael, W. Liauw, S-A. McLachlan, E. Link, A. Matera, M. Thompson, M. Jefford, R.J. Hicks, C. Cullinane, I. Campbell, P.J. Beale, C.S. Karapetis, T.J. Price, M.E. Burge
dc.identifier.citationAnnals of Oncology, 2017, vol.28, iss.Suppl. 5, pp.134-135
dc.identifier.doi10.1093/annonc/mdx367.038
dc.identifier.issn0923-7534
dc.identifier.issn1569-8041
dc.identifier.orcidPrice, T.J. [0000-0002-3922-2693]
dc.identifier.urihttps://hdl.handle.net/2440/138595
dc.language.isoen
dc.publisherElsevier
dc.relation.grantNHMRC
dc.rights© 2017 European Society for Medical Oncology. Published by Elsevier Inc.
dc.source.urihttps://www.annalsofoncology.org/issue/S0923-7534(17)X9800-1
dc.titleHepatic functional imaging and genomics to predict irinotecan pharmacokinetics and pharmacodynamics: The PREDICT IR study
dc.typeConference item
pubs.publication-statusPublished

Files

Collections

Medicine publications